Climb Bio Inc.

NASDAQ: CLYM · Real-Time Price · USD
1.93
0.21 (12.21%)
At close: Aug 15, 2025, 3:59 PM
1.92
-0.55%
After-hours: Aug 15, 2025, 07:44 PM EDT

Climb Bio Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
87.23M 93.11M 43.59M 46.92M
Short-Term Investments
63.69M 13.69M 79.98M 89.56M
Long-Term Investments
61.61M n/a n/a 24.92M
Other Long-Term Assets
215K 15K 128K 70K
Receivables
1.12M 2.46M 6.49M 6.52M
Inventory
n/a n/a n/a n/a
Other Current Assets
256K 112K 3M 852K
Total Current Assets
154.87M 110.25M 134.39M 148.25M
Property-Plant & Equipment
490K 199K 471K n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
62.31M 214K 599K 24.99M
Total Assets
217.19M 110.47M 134.99M 173.24M
Account Payables
705K 66K 750K 1.4M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
157K 334K 300K n/a
Other Current Liabilities
-126K -196K -300K n/a
Total Current Liabilities
4.93M 2.83M 6.1M 6.03M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 22K n/a 7K
Total Long-Term Liabilities
375K 37K 180K 7K
Total Liabilities
5.31M 2.87M 6.28M 6.04M
Total Debt
532K 349K 480K n/a
Common Stock
7K 3K 3K 3K
Retained Earnings
-229.88M -155.98M -120.86M -75.62M
Comprehensive Income
23K -2K -358K -123K
Shareholders Equity
211.88M 107.6M 128.72M 167.2M
Total Investments
125.3M 13.69M 79.98M 114.48M